NASDAQ:NMRD Nemaura Medical (NMRD) Stock Price, News & Analysis $0.03 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.03▼$0.0650-Day Range$0.03▼$0.0652-Week Range$0.03▼$1.00Volume5,491 shsAverage Volume60,119 shsMarket Capitalization$1.30 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsSustainabilityTrends Get Nemaura Medical alerts: Email Address Nemaura Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside7,688.2% Upside$2.50 Price TargetShort InterestN/ADividend StrengthN/ASustainability-0.97Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.34 out of 5 stars 3.5 Analyst's Opinion Consensus RatingNemaura Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNemaura Medical has received no research coverage in the past 90 days.Read more about Nemaura Medical's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for NMRD. Previous Next 0.0 Dividend Strength Dividend YieldNemaura Medical does not currently pay a dividend.Dividend GrowthNemaura Medical does not have a long track record of dividend growth. Previous Next 4.5 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreNemaura Medical has received a 69.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Continuous glucose monitoring systems", "Continuous substance abuse monitoring systems", and "Continuous alcohol monitoring systems" products. See details.Environmental SustainabilityThe Environmental Impact score for Nemaura Medical is -0.97. Previous Next N/A News and Social Media Coverage Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Nemaura Medical insiders have not sold or bought any company stock.Percentage Held by Insiders40.42% of the stock of Nemaura Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 4.41% of the stock of Nemaura Medical is held by institutions.Read more about Nemaura Medical's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Nemaura Medical is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nemaura Medical is -0.08, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE About Nemaura Medical Stock (NASDAQ:NMRD)Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.Read More NMRD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NMRD Stock News HeadlinesMay 26, 2024 | investing.comNemaura Medical Inc (NMRD)May 24, 2024 | seekingalpha.comNXNN Nexeon Medsystems IncJuly 26, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.February 23, 2024 | benzinga.comNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning CallsJanuary 22, 2024 | finance.yahoo.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 3, 2024 | finanznachrichten.deNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finance.yahoo.comImportant Update on Listing Status and Strategic DirectionDecember 20, 2023 | markets.businessinsider.comBuy Rating Affirmed for Nemaura Medical on sugarBEAT Prospects and Market ExpansionJuly 26, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.December 13, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finance.yahoo.comNemaura Medical Inc. Receives Positive Nasdaq Listing DecisionNovember 27, 2023 | msn.comNemaura Medical (NMRD) Price Target Increased by 54.55% to 8.67November 21, 2023 | finance.yahoo.comNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthNovember 17, 2023 | msn.comNemaura (NMRD) to Expand in UK With Metabolic Health ProgramNovember 16, 2023 | finance.yahoo.comNemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)November 15, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateNovember 14, 2023 | seekingalpha.comAcutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2MNovember 14, 2023 | finanznachrichten.deNemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsSee More Headlines Receive NMRD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nemaura Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/12/2024Today7/26/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NMRD CUSIPN/A CIK1602078 Webnemauramedical.com Phone(646) 416-8000FaxN/AEmployees36Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$2.50 Low Stock Price Target$2.50 Potential Upside/Downside+7,688.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.39) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,140,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-142.69% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.03 Sales & Book Value Annual Sales$80,000.00 Price / Sales16.19 Cash FlowN/A Price / Cash FlowN/A Book Value($0.41) per share Price / Book-0.08Miscellaneous Outstanding Shares40,350,000Free Float24,042,000Market Cap$1.30 million OptionableNo Data Beta-0.03 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesDr. Dewan Fazlul Hoque Chowdhury Ph.D. (Age 51)Chairman, Interim CFO, CEO, President and Principal Financial & Accounting Officer Comp: $338.58kDr. Arash Ghadar (Age 47)Chief Operating Officer Mr. Jay L. WarnerHead of U.S. Commercial OperationsMr. Thomas Bendix MortensenHead of E.U. Commercial Operations & MarketingMs. Samantha SandersGlobal Head of Digital ProgramsKey CompetitorsTitan MedicalNASDAQ:TMDIFIntelligent Bio SolutionsNASDAQ:INBSXylo TechnologiesNASDAQ:XLYOVenus ConceptNASDAQ:VEROSharps TechnologyNASDAQ:STSSView All CompetitorsInsidersArash Ghadar-GhadrBought 100,000 shares on 1/5/2024Total: $14,000.00 ($0.14/share)View All Insider Transactions NMRD Stock Analysis - Frequently Asked Questions How have NMRD shares performed this year? Nemaura Medical's stock was trading at $0.2190 at the beginning of 2024. Since then, NMRD shares have decreased by 85.3% and is now trading at $0.0321. View the best growth stocks for 2024 here. How were Nemaura Medical's earnings last quarter? Nemaura Medical Inc. (NASDAQ:NMRD) issued its quarterly earnings results on Monday, February, 12th. The company reported ($0.12) earnings per share for the quarter. How do I buy shares of Nemaura Medical? Shares of NMRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NMRD) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.